HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jianguo Xu Selected Research

Jianguo Xu Research Topics

Disease

54Neoplasms (Cancer)
01/2022 - 04/2002
19Sepsis (Septicemia)
01/2022 - 01/2002
16Traumatic Brain Injuries (Traumatic Brain Injury)
06/2022 - 01/2013
15Neuralgia (Stump Neuralgia)
01/2021 - 08/2003
15Infections
01/2021 - 11/2005
12Inflammation (Inflammations)
01/2021 - 08/2005
12Lung Injury
01/2021 - 02/2005
12Hyperalgesia
09/2014 - 01/2006
11Glioblastoma (Glioblastoma Multiforme)
09/2022 - 08/2014
11Glioma (Gliomas)
01/2022 - 09/2013
11Craniopharyngioma (Craniopharyngiomas)
01/2017 - 01/2006
9Brain Injuries (Brain Injury)
05/2022 - 06/2014
8Wounds and Injuries (Trauma)
01/2021 - 08/2010
7Brain Edema (Cerebral Edema)
01/2022 - 08/2010
7Neuroinflammatory Diseases
01/2021 - 02/2007
7Fibrosis (Cirrhosis)
01/2012 - 08/2005
6Pain (Aches)
12/2021 - 01/2006
6Necrosis
01/2020 - 04/2006
6Neoplasm Metastasis (Metastasis)
04/2019 - 12/2010
5Pneumonia (Pneumonitis)
07/2022 - 09/2006
5Cerebral Hemorrhage
01/2021 - 08/2018
5Acute Lung Injury
01/2021 - 02/2005
5Hepatocellular Carcinoma (Hepatoma)
01/2021 - 04/2019
4Carcinogenesis
01/2022 - 10/2006
4Stroke (Strokes)
10/2021 - 11/2016
4Brain Ischemia (Cerebral Ischemia)
01/2017 - 12/2008
4Weight Loss (Weight Reduction)
01/2016 - 08/2010
3Epilepsy (Aura)
02/2022 - 09/2011
3Central Serous Chorioretinopathy
01/2022 - 01/2021
3Ischemia
10/2021 - 01/2006
3Ischemic Stroke
10/2021 - 01/2018
3Hypoxia (Hypoxemia)
10/2020 - 01/2014
3Melanoma (Melanoma, Malignant)
04/2020 - 09/2009
3Brain Neoplasms (Brain Tumor)
01/2020 - 02/2012
3Septic Shock (Toxic Shock Syndrome)
01/2019 - 01/2013
3Bronchiolitis
01/2017 - 12/2008
3Bacillary Dysentery (Shigellosis)
07/2015 - 02/2010
3Reperfusion Injury
02/2015 - 12/2008
3Meningitis
03/2013 - 01/2009

Drug/Important Bio-Agent (IBA)

25CytokinesIBA
01/2021 - 01/2002
24Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2002
16NF-kappa B (NF-kB)IBA
08/2017 - 01/2005
11Biomarkers (Surrogate Marker)IBA
06/2022 - 04/2014
11Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 01/2002
10MicroRNAs (MicroRNA)IBA
05/2022 - 07/2018
10Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2002
9Messenger RNA (mRNA)IBA
06/2020 - 01/2002
8Bleomycin (Blenoxane)FDA LinkGeneric
11/2012 - 08/2005
7EnzymesIBA
01/2022 - 04/2006
7Pharmaceutical PreparationsIBA
06/2019 - 09/2010
7DNA (Deoxyribonucleic Acid)IBA
01/2017 - 06/2007
6AntigensIBA
01/2020 - 04/2002
6Neuroprotective AgentsIBA
01/2016 - 01/2013
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 01/2006
5Phosphotransferases (Kinase)IBA
01/2021 - 01/2014
5salicylhydroxamic acid (SHAM)IBA
02/2015 - 01/2007
5Interleukin-10 (Interleukin 10)IBA
08/2013 - 01/2006
4CateninsIBA
05/2022 - 12/2015
4VaccinesIBA
01/2021 - 02/2010
4AntibodiesIBA
10/2020 - 11/2008
4LuteolinIBA
06/2020 - 06/2014
4Therapeutic UsesIBA
01/2020 - 08/2002
4LipopolysaccharidesIBA
01/2020 - 01/2003
4Biological ProductsIBA
10/2019 - 10/2006
470-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
07/2015 - 07/2014
4HES 130-0.4IBA
08/2010 - 09/2006
4Starch (Cornstarch)IBA
08/2010 - 01/2005
4Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2008 - 03/2006
4Pentoxifylline (Trental)FDA LinkGeneric
02/2008 - 01/2006
3Blood Glucose (Blood Sugar)IBA
01/2022 - 08/2017
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022 - 01/2020
3Nucleic AcidsIBA
12/2021 - 01/2016
3Hyaluronic Acid (Hyaluronan)IBA
04/2021 - 12/2011
3Chimeric Antigen ReceptorsIBA
01/2021 - 01/2020
3Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 01/2018
3CreatinineIBA
01/2021 - 04/2002
3Caspase 3 (Caspase-3)IBA
01/2021 - 06/2007
3Peptides (Polypeptides)IBA
06/2019 - 04/2014
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2019 - 01/2006
3fibrin fragment D (D-dimer)IBA
01/2019 - 01/2018
3Mifepristone (RU 486)FDA Link
01/2019 - 09/2014
3RNA (Ribonucleic Acid)IBA
12/2018 - 06/2012
3metapristoneIBA
12/2017 - 09/2014
3Fingolimod Hydrochloride (FTY720)FDA Link
01/2016 - 11/2014
3MelatoninIBA
12/2015 - 08/2014
3Mirtazapine (Rexer)FDA LinkGeneric
09/2013 - 03/2008
3Toll-Like Receptors (Toll-Like Receptor)IBA
01/2013 - 08/2007
3Interleukin-12 (IL 12)IBA
02/2012 - 04/2002
3Evans Blue (Blue, Evans)FDA Link
08/2010 - 04/2006
3InterleukinsIBA
08/2010 - 02/2007

Therapy/Procedure

22Therapeutics
12/2021 - 04/2002
9Ligation
01/2020 - 01/2007
5Drug Therapy (Chemotherapy)
01/2022 - 10/2016
5Radiotherapy
01/2021 - 11/2012
5Punctures
01/2020 - 01/2007
4Aftercare (After-Treatment)
01/2021 - 08/2010
3Laser Therapy (Surgery, Laser)
01/2022 - 01/2021
3Craniotomy
12/2021 - 02/2012
3Immunotherapy
08/2020 - 01/2020
3Lung Transplantation
01/2017 - 12/2008